Legend Biotech Corp ADR [LEGN] stock prices are up 3.63% to $32.85 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The LEGN shares have gain 4.48% over the last week, with a monthly amount drifted -0.79%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Legend Biotech Corp ADR [NASDAQ: LEGN] stock has seen the most recent analyst activity on October 07, 2025, when Cantor Fitzgerald initiated its Overweight rating and assigned the stock a price target of $40. Previously, Redburn Atlantic started tracking the stock with Buy rating on October 08, 2024, and set its price target to $86. On June 17, 2024, Truist initiated with a Buy rating and assigned a price target of $88 on the stock. H.C. Wainwright reiterated its Buy rating and decreased its price target to $73 on May 24, 2024. Deutsche Bank initiated its recommendation with a Buy and recommended $60 as its price target on May 23, 2024. Scotiabank upgraded its rating to Sector Outperform for this stock on April 17, 2024, but kept the price target unchanged to $65. In a note dated April 03, 2024, Cantor Fitzgerald initiated an Overweight rating and provided a target price of $82 on this stock.
The stock price of Legend Biotech Corp ADR [LEGN] has been fluctuating between $27.34 and $51.77 over the past year. Currently, Wall Street analysts expect the stock to reach $54 within the next 12 months. Legend Biotech Corp ADR [NASDAQ: LEGN] shares were valued at $32.85 at the most recent close of the market. An investor can expect a potential return of 64.38% based on the average LEGN price forecast.
Analyzing the LEGN fundamentals
The Legend Biotech Corp ADR [NASDAQ:LEGN] reported sales of 798.01M for trailing twelve months, representing a surge of 37.22%. Gross Profit Margin for this corporation currently stands at 0.62% with Operating Profit Margin at -0.27%, Pretax Profit Margin comes in at -0.38%, and Net Profit Margin reading is -0.41%. To continue investigating profitability, this company’s Return on Assets is posted at -0.19, Equity is -0.31 and Total Capital is -0.15. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.37.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that Legend Biotech Corp ADR [NASDAQ:LEGN]’s Current Ratio is 4.71. Also, the Quick Ratio is 4.57, while the Cash Ratio stands at 1.0. Considering the valuation of this stock, the price to sales ratio is 7.60, the price to book ratio is 5.85.
Transactions by insiders
Recent insider trading involved Casey Patrick John, Director, that happened on Sep 26 ’25 when 1000.0 shares were purchased. Officer, Huang Ying completed a deal on Sep 24 ’25 to buy 1370.0 shares. Meanwhile, Officer Huang Ying bought 1357.0 shares on Sep 23 ’25.
